|
| Santaris Pharma a/s business strategy is to leverage the Company's technology platform and become: |
| |
- A leading company in the RNA-medicines field (targeting both messengerRNA and microRNA)
|
- A preferred partner for the discovery and development of effective designer drugs for RNA-targeted therapy
|
|
|
|